Global Molecular Diagnostics Systems Market Insights and Forecast to 2031

Report ID: 1564811 | Published Date: Oct 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Molecular Diagnostics Systems Product Introduction
    1.2 Market by Type
        1.2.1 Global Molecular Diagnostics Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 PCR
        1.2.3 Hybridization
        1.2.4 DNA Sequencing
    1.3 Market by Application
        1.3.1 Global Molecular Diagnostics Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Laboratories
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Molecular Diagnostics Systems Sales Estimates and Forecasts 2017-2028
    2.2 Global Molecular Diagnostics Systems Revenue Estimates and Forecasts 2017-2028
    2.3 Global Molecular Diagnostics Systems Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Molecular Diagnostics Systems Sales by Region
        2.4.1 Global Molecular Diagnostics Systems Sales by Region (2017-2022)
        2.4.2 Global Sales Molecular Diagnostics Systems by Region (2023-2028)
    2.5 Global Molecular Diagnostics Systems Revenue by Region
        2.5.1 Global Molecular Diagnostics Systems Revenue by Region (2017-2022)
        2.5.2 Global Molecular Diagnostics Systems Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Molecular Diagnostics Systems Sales by Manufacturers
        3.1.1 Global Top Molecular Diagnostics Systems Manufacturers by Sales (2017-2022)
        3.1.2 Global Molecular Diagnostics Systems Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Molecular Diagnostics Systems in 2021
    3.2 Global Molecular Diagnostics Systems Revenue by Manufacturers
        3.2.1 Global Molecular Diagnostics Systems Revenue by Manufacturers (2017-2022)
        3.2.2 Global Molecular Diagnostics Systems Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Molecular Diagnostics Systems Revenue in 2021
    3.3 Global Molecular Diagnostics Systems Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Molecular Diagnostics Systems Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Molecular Diagnostics Systems Sales by Type
        4.1.1 Global Molecular Diagnostics Systems Historical Sales by Type (2017-2022)
        4.1.2 Global Molecular Diagnostics Systems Forecasted Sales by Type (2023-2028)
        4.1.3 Global Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    4.2 Global Molecular Diagnostics Systems Revenue by Type
        4.2.1 Global Molecular Diagnostics Systems Historical Revenue by Type (2017-2022)
        4.2.2 Global Molecular Diagnostics Systems Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    4.3 Global Molecular Diagnostics Systems Price by Type
        4.3.1 Global Molecular Diagnostics Systems Price by Type (2017-2022)
        4.3.2 Global Molecular Diagnostics Systems Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Molecular Diagnostics Systems Sales by Application
        5.1.1 Global Molecular Diagnostics Systems Historical Sales by Application (2017-2022)
        5.1.2 Global Molecular Diagnostics Systems Forecasted Sales by Application (2023-2028)
        5.1.3 Global Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    5.2 Global Molecular Diagnostics Systems Revenue by Application
        5.2.1 Global Molecular Diagnostics Systems Historical Revenue by Application (2017-2022)
        5.2.2 Global Molecular Diagnostics Systems Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    5.3 Global Molecular Diagnostics Systems Price by Application
        5.3.1 Global Molecular Diagnostics Systems Price by Application (2017-2022)
        5.3.2 Global Molecular Diagnostics Systems Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Molecular Diagnostics Systems Market Size by Type
        6.1.1 North America Molecular Diagnostics Systems Sales by Type (2017-2028)
        6.1.2 North America Molecular Diagnostics Systems Revenue by Type (2017-2028)
    6.2 North America Molecular Diagnostics Systems Market Size by Application
        6.2.1 North America Molecular Diagnostics Systems Sales by Application (2017-2028)
        6.2.2 North America Molecular Diagnostics Systems Revenue by Application (2017-2028)
    6.3 North America Molecular Diagnostics Systems Market Size by Country
        6.3.1 North America Molecular Diagnostics Systems Sales by Country (2017-2028)
        6.3.2 North America Molecular Diagnostics Systems Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Molecular Diagnostics Systems Market Size by Type
        7.1.1 Europe Molecular Diagnostics Systems Sales by Type (2017-2028)
        7.1.2 Europe Molecular Diagnostics Systems Revenue by Type (2017-2028)
    7.2 Europe Molecular Diagnostics Systems Market Size by Application
        7.2.1 Europe Molecular Diagnostics Systems Sales by Application (2017-2028)
        7.2.2 Europe Molecular Diagnostics Systems Revenue by Application (2017-2028)
    7.3 Europe Molecular Diagnostics Systems Market Size by Country
        7.3.1 Europe Molecular Diagnostics Systems Sales by Country (2017-2028)
        7.3.2 Europe Molecular Diagnostics Systems Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Molecular Diagnostics Systems Market Size by Type
        8.1.1 Asia Pacific Molecular Diagnostics Systems Sales by Type (2017-2028)
        8.1.2 Asia Pacific Molecular Diagnostics Systems Revenue by Type (2017-2028)
    8.2 Asia Pacific Molecular Diagnostics Systems Market Size by Application
        8.2.1 Asia Pacific Molecular Diagnostics Systems Sales by Application (2017-2028)
        8.2.2 Asia Pacific Molecular Diagnostics Systems Revenue by Application (2017-2028)
    8.3 Asia Pacific Molecular Diagnostics Systems Market Size by Region
        8.3.1 Asia Pacific Molecular Diagnostics Systems Sales by Region (2017-2028)
        8.3.2 Asia Pacific Molecular Diagnostics Systems Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Molecular Diagnostics Systems Market Size by Type
        9.1.1 Latin America Molecular Diagnostics Systems Sales by Type (2017-2028)
        9.1.2 Latin America Molecular Diagnostics Systems Revenue by Type (2017-2028)
    9.2 Latin America Molecular Diagnostics Systems Market Size by Application
        9.2.1 Latin America Molecular Diagnostics Systems Sales by Application (2017-2028)
        9.2.2 Latin America Molecular Diagnostics Systems Revenue by Application (2017-2028)
    9.3 Latin America Molecular Diagnostics Systems Market Size by Country
        9.3.1 Latin America Molecular Diagnostics Systems Sales by Country (2017-2028)
        9.3.2 Latin America Molecular Diagnostics Systems Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Molecular Diagnostics Systems Market Size by Type
        10.1.1 Middle East and Africa Molecular Diagnostics Systems Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Type (2017-2028)
    10.2 Middle East and Africa Molecular Diagnostics Systems Market Size by Application
        10.2.1 Middle East and Africa Molecular Diagnostics Systems Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Application (2017-2028)
    10.3 Middle East and Africa Molecular Diagnostics Systems Market Size by Country
        10.3.1 Middle East and Africa Molecular Diagnostics Systems Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Corporation Information
        11.1.2 Abbott Laboratories Overview
        11.1.3 Abbott Laboratories Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Laboratories Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Qiagen N.V.
        11.2.1 Qiagen N.V. Corporation Information
        11.2.2 Qiagen N.V. Overview
        11.2.3 Qiagen N.V. Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Qiagen N.V. Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Qiagen N.V. Recent Developments
    11.3 Roche Diagnostics
        11.3.1 Roche Diagnostics Corporation Information
        11.3.2 Roche Diagnostics Overview
        11.3.3 Roche Diagnostics Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Diagnostics Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Diagnostics Recent Developments
    11.4 Hologic, Inc.
        11.4.1 Hologic, Inc. Corporation Information
        11.4.2 Hologic, Inc. Overview
        11.4.3 Hologic, Inc. Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Hologic, Inc. Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Hologic, Inc. Recent Developments
    11.5 Grifols
        11.5.1 Grifols Corporation Information
        11.5.2 Grifols Overview
        11.5.3 Grifols Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Grifols Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Grifols Recent Developments
    11.6 Siemens Healthcare
        11.6.1 Siemens Healthcare Corporation Information
        11.6.2 Siemens Healthcare Overview
        11.6.3 Siemens Healthcare Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Siemens Healthcare Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Siemens Healthcare Recent Developments
    11.7 Becton, Dickinson and Company
        11.7.1 Becton, Dickinson and Company Corporation Information
        11.7.2 Becton, Dickinson and Company Overview
        11.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Becton, Dickinson and Company Recent Developments
    11.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
        11.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
        11.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Overview
        11.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments
    11.9 Biomérieux Sa
        11.9.1 Biomérieux Sa Corporation Information
        11.9.2 Biomérieux Sa Overview
        11.9.3 Biomérieux Sa Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Biomérieux Sa Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Biomérieux Sa Recent Developments
    11.10 Cepheid Inc
        11.10.1 Cepheid Inc Corporation Information
        11.10.2 Cepheid Inc Overview
        11.10.3 Cepheid Inc Molecular Diagnostics Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Cepheid Inc Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Cepheid Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Molecular Diagnostics Systems Industry Chain Analysis
    12.2 Molecular Diagnostics Systems Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Molecular Diagnostics Systems Production Mode & Process
    12.4 Molecular Diagnostics Systems Sales and Marketing
        12.4.1 Molecular Diagnostics Systems Sales Channels
        12.4.2 Molecular Diagnostics Systems Distributors
    12.5 Molecular Diagnostics Systems Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Molecular Diagnostics Systems Industry Trends
    13.2 Molecular Diagnostics Systems Market Drivers
    13.3 Molecular Diagnostics Systems Market Challenges
    13.4 Molecular Diagnostics Systems Market Restraints
14 Key Findings in The Global Molecular Diagnostics Systems Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Molecular Diagnostics Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of PCR
    Table 3. Major Manufacturers of Hybridization
    Table 4. Major Manufacturers of DNA Sequencing
    Table 5. Global Molecular Diagnostics Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Molecular Diagnostics Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Molecular Diagnostics Systems Sales by Region (2017-2022) & (K Units)
    Table 8. Global Molecular Diagnostics Systems Sales Market Share by Region (2017-2022)
    Table 9. Global Molecular Diagnostics Systems Sales by Region (2023-2028) & (K Units)
    Table 10. Global Molecular Diagnostics Systems Sales Market Share by Region (2023-2028)
    Table 11. Global Molecular Diagnostics Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Molecular Diagnostics Systems Revenue Market Share by Region (2017-2022)
    Table 13. Global Molecular Diagnostics Systems Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Molecular Diagnostics Systems Revenue Market Share by Region (2023-2028)
    Table 15. Global Molecular Diagnostics Systems Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Molecular Diagnostics Systems Sales Share by Manufacturers (2017-2022)
    Table 17. Global Molecular Diagnostics Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Molecular Diagnostics Systems Revenue Share by Manufacturers (2017-2022)
    Table 19. Molecular Diagnostics Systems Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Molecular Diagnostics Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Molecular Diagnostics Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Systems as of 2021)
    Table 22. Molecular Diagnostics Systems Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Molecular Diagnostics Systems Product Offered
    Table 24. Date of Manufacturers Enter into Molecular Diagnostics Systems Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
    Table 27. Global Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
    Table 28. Global Molecular Diagnostics Systems Sales Share by Type (2017-2022)
    Table 29. Global Molecular Diagnostics Systems Sales Share by Type (2023-2028)
    Table 30. Global Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Molecular Diagnostics Systems Revenue Share by Type (2017-2022)
    Table 33. Global Molecular Diagnostics Systems Revenue Share by Type (2023-2028)
    Table 34. Molecular Diagnostics Systems Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Molecular Diagnostics Systems Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
    Table 37. Global Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
    Table 38. Global Molecular Diagnostics Systems Sales Share by Application (2017-2022)
    Table 39. Global Molecular Diagnostics Systems Sales Share by Application (2023-2028)
    Table 40. Global Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Molecular Diagnostics Systems Revenue Share by Application (2017-2022)
    Table 43. Global Molecular Diagnostics Systems Revenue Share by Application (2023-2028)
    Table 44. Molecular Diagnostics Systems Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Molecular Diagnostics Systems Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
    Table 47. North America Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
    Table 48. North America Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
    Table 51. North America Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
    Table 52. North America Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
    Table 55. North America Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
    Table 56. North America Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Molecular Diagnostics Systems Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Molecular Diagnostics Systems Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Molecular Diagnostics Systems Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Molecular Diagnostics Systems Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Molecular Diagnostics Systems Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Molecular Diagnostics Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Molecular Diagnostics Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Molecular Diagnostics Systems Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Molecular Diagnostics Systems Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Molecular Diagnostics Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Molecular Diagnostics Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Molecular Diagnostics Systems Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Molecular Diagnostics Systems Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Molecular Diagnostics Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Abbott Laboratories Corporation Information
    Table 107. Abbott Laboratories Description and Major Businesses
    Table 108. Abbott Laboratories Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Abbott Laboratories Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Abbott Laboratories Recent Developments
    Table 111. Qiagen N.V. Corporation Information
    Table 112. Qiagen N.V. Description and Major Businesses
    Table 113. Qiagen N.V. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Qiagen N.V. Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Qiagen N.V. Recent Developments
    Table 116. Roche Diagnostics Corporation Information
    Table 117. Roche Diagnostics Description and Major Businesses
    Table 118. Roche Diagnostics Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Roche Diagnostics Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Roche Diagnostics Recent Developments
    Table 121. Hologic, Inc. Corporation Information
    Table 122. Hologic, Inc. Description and Major Businesses
    Table 123. Hologic, Inc. Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Hologic, Inc. Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Hologic, Inc. Recent Developments
    Table 126. Grifols Corporation Information
    Table 127. Grifols Description and Major Businesses
    Table 128. Grifols Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Grifols Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Grifols Recent Developments
    Table 131. Siemens Healthcare Corporation Information
    Table 132. Siemens Healthcare Description and Major Businesses
    Table 133. Siemens Healthcare Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Siemens Healthcare Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Siemens Healthcare Recent Developments
    Table 136. Becton, Dickinson and Company Corporation Information
    Table 137. Becton, Dickinson and Company Description and Major Businesses
    Table 138. Becton, Dickinson and Company Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Becton, Dickinson and Company Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Becton, Dickinson and Company Recent Developments
    Table 141. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Corporation Information
    Table 142. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Description and Major Businesses
    Table 143. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Recent Developments
    Table 146. Biomérieux Sa Corporation Information
    Table 147. Biomérieux Sa Description and Major Businesses
    Table 148. Biomérieux Sa Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Biomérieux Sa Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Biomérieux Sa Recent Developments
    Table 151. Cepheid Inc Corporation Information
    Table 152. Cepheid Inc Description and Major Businesses
    Table 153. Cepheid Inc Molecular Diagnostics Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Cepheid Inc Molecular Diagnostics Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Cepheid Inc Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. Molecular Diagnostics Systems Distributors List
    Table 159. Molecular Diagnostics Systems Customers List
    Table 160. Molecular Diagnostics Systems Market Trends
    Table 161. Molecular Diagnostics Systems Market Drivers
    Table 162. Molecular Diagnostics Systems Market Challenges
    Table 163. Molecular Diagnostics Systems Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Molecular Diagnostics Systems Product Picture
    Figure 3. Global Molecular Diagnostics Systems Market Share by Type in 2021 & 2028
    Figure 3. PCR Product Picture
    Figure 4. Hybridization Product Picture
    Figure 5. DNA Sequencing Product Picture
    Figure 6. Global Molecular Diagnostics Systems Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Laboratories
    Figure 9. Molecular Diagnostics Systems Report Years Considered
    Figure 10. Global Molecular Diagnostics Systems Sales 2017-2028 (K Units)
    Figure 11. Global Molecular Diagnostics Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Molecular Diagnostics Systems Revenue 2017-2028 (US$ Million)
    Figure 13. Global Molecular Diagnostics Systems Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Molecular Diagnostics Systems Sales Market Share by Region (2017-2022)
    Figure 15. Global Molecular Diagnostics Systems Sales Market Share by Region (2023-2028)
    Figure 16. North America Molecular Diagnostics Systems Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Molecular Diagnostics Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Molecular Diagnostics Systems Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Molecular Diagnostics Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Molecular Diagnostics Systems Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Molecular Diagnostics Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Molecular Diagnostics Systems Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Molecular Diagnostics Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Molecular Diagnostics Systems Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Molecular Diagnostics Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Molecular Diagnostics Systems Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Molecular Diagnostics Systems in the World: Market Share by Molecular Diagnostics Systems Revenue in 2021
    Figure 28. Global Molecular Diagnostics Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    Figure 30. Global Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    Figure 31. Global Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    Figure 32. Global Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    Figure 33. North America Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    Figure 34. North America Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    Figure 35. North America Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    Figure 36. North America Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    Figure 37. North America Molecular Diagnostics Systems Sales Share by Country (2017-2028)
    Figure 38. North America Molecular Diagnostics Systems Revenue Share by Country (2017-2028)
    Figure 39. U.S. Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    Figure 42. Europe Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    Figure 44. Europe Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Molecular Diagnostics Systems Sales Share by Country (2017-2028)
    Figure 46. Europe Molecular Diagnostics Systems Revenue Share by Country (2017-2028)
    Figure 47. Germany Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 48. France Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Molecular Diagnostics Systems Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Molecular Diagnostics Systems Revenue Share by Region (2017-2028)
    Figure 58. China Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 61. India Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Molecular Diagnostics Systems Sales Share by Country (2017-2028)
    Figure 72. Latin America Molecular Diagnostics Systems Revenue Share by Country (2017-2028)
    Figure 73. Mexico Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Molecular Diagnostics Systems Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Molecular Diagnostics Systems Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Molecular Diagnostics Systems Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Molecular Diagnostics Systems Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Molecular Diagnostics Systems Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Molecular Diagnostics Systems Revenue Share by Country (2017-2028)
    Figure 82. Turkey Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Molecular Diagnostics Systems Revenue (2017-2028) & (US$ Million)
    Figure 85. Molecular Diagnostics Systems Value Chain
    Figure 86. Molecular Diagnostics Systems Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biomérieux Sa
Cepheid Inc
Frequently Asked Questions
Molecular Diagnostics Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Molecular Diagnostics Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Molecular Diagnostics Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports